Skip to content

Blend Labs BLND Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)

Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) at other companies

Unifirst logo
UnifirstUNF
$5.66M-35.7%
CorMedix logo
CorMedixCRMD
$0-100%
Alignment Healthcare logo
Alignment HealthcareALHC
$20.71M-37.9%
IPG Photonics logo
IPG PhotonicsIPGP
$332.14M-41.1%
PennyMac Financial Services, Inc. logo
PennyMac Financial Services, Inc.PFSI
$434.22M-2.1%
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
$278.14M+150%

Other financials

Income statement

See full
Revenue$30.8M+14.9%
Gross profit$23.4M+23.0%
Operating income-$5.1M+36.6%
Net income-$8.0M+15.4%
EPS (diluted)-$0.05+16.7%

Balance sheet

See full
Cash & equivalents$39.4M-35.7%
Total debt$1.4M-20.8%
Total equity-$55.9M-226%
Total assets$161.3M-14.0%

Cash flow

See full
Operating cash flow$7.4M-63.5%
CapEx$1.1M-74.1%
Free cash flow$6.2M-60.5%

Valuation

See full
Market cap$392.23M-52.3%
Enterprise value$354.22M-53.5%
P/S3.1×-3.8×

Profitability

See full
Gross margin74.9%+2.3pp
Operating margin-14.7%-5.0pp
Net margin-4.2%-1.9pp
FCF margin-7.6%-8.9pp

Returns & leverage

See full
Return on equity-251.8%+881pp
Debt / equity36.8×+35.5×
Current ratio1.8×-0.6×

Where this comes from

Reported directly by Blend Labs in its filing.

Tagged under the XBRL concept us-gaap:ShortTermInvestments.

The official record: Blend Labs’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Blend Labs's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Blend Labs's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)?
Blend Labs (BLND) reported short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) of $21.61M in Q1 2026.
How has Blend Labs's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) changed year-over-year?
Blend Labs's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) decreased by 55.5% year-over-year, from $48.57M to $21.61M.
What is the long-term trend for Blend Labs's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)?
Over 3 years (2022 to 2025), Blend Labs's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) has grown at a -52.4% compound annual growth rate (CAGR), from $229.95M to $24.74M.
What does short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) mean?
This represents financial instruments held by the company with maturities greater than one year that are intended to be held for investment purposes rather than immediate liquidity. These assets are often managed to generate returns on excess cash while maintaining a degree of flexibility for future capital needs. It may include restricted assets associated with specific consolidated entities.